Evaluation of negative-pressure wound therapy for patients with diabetic foot ulcers: systematic review and meta-analysis
- PMID: 28458556
- PMCID: PMC5403129
- DOI: 10.2147/TCRM.S131193
Evaluation of negative-pressure wound therapy for patients with diabetic foot ulcers: systematic review and meta-analysis
Abstract
Objectives: The aim of this study was to perform an updated systematic review and meta-analysis to assess the clinical efficacy, safety, and cost-effectiveness of negative-pressure wound therapy (NPWT) in the treatment of diabetic foot ulcers (DFUs).
Methods: We searched the Cochrane Library, MEDLINE, EMBASE, Ovid, and Chinese Biological Medicine databases up to June 30, 2016. We also manually searched the articles from reference lists of the retrieved articles, which used the NPWT system in studies of vacuum-assisted closure therapy. Studies were identified and selected, and two independent reviewers extracted data from the studies.
Results: A total of eleven randomized controlled trials, which included a total of 1,044 patients, were selected from 691 identified studies. Compared with standard dressing changes, NPWT had a higher rate of complete healing of ulcers (relative risk, 1.48; 95% confidence interval [CI]: 1.24-1.76; P<0.001), shorter healing time (mean difference, -8.07; 95% CI: -13.70- -2.45; P=0.005), greater reduction in ulcer area (mean difference, 12.18; 95% CI: 8.50-15.86; P<0.00001), greater reduction in ulcer depth (mean difference, 40.82; 95% CI: 35.97-45.67; P<0.00001), fewer amputations (relative risk, 0.31; 95% CI: 0.15-0.62; P=0.001), and no effect on the incidence of treatment-related adverse effects (relative risk, 1.12; 95% CI: 0.66-1.89; P=0.68). Meanwhile, many analyses showed that the NPWT was more cost-effective than standard dressing changes.
Conclusion: These results indicate that NPWT is efficacious, safe, and cost-effective in treating DFUs.
Keywords: amputation; complete wound closure; cost-effectiveness; diabetic foot ulcers; meta-analysis; negative-pressure wound therapy.
Conflict of interest statement
Disclosure The authors report no conflicts of interest in this work.
Figures










References
-
- Heublein H, Bader A, Giri S. Preclinical and clinical evidence for stem cell therapies as treatment for diabetic wounds. Drug Discov Today. 2015;20(6):703–717. - PubMed
-
- Boulton AJ. The diabetic foot. Medicine. 2010;38(12):644–648.
-
- Setacci F, Sirignano P, De Donato G, et al. Primary amputation: is there still a place for it. J Cardiovasc Surg (Torino) 2012;53(1):53–59. - PubMed
Publication types
LinkOut - more resources
Full Text Sources